SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01000558|
Recruitment Status : Completed
First Posted : October 23, 2009
Last Update Posted : May 20, 2013
RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future.
PURPOSE: This research study is collecting and storing blood samples from patients with previously untreated non-Hodgkin lymphoma.
|Condition or disease||Intervention/treatment|
|Lymphoma||Other: biologic sample preservation procedure|
- To establish a central lymphoma serum repository that will serve as a resource to provide specimens for current and future scientific studies.
- To utilize the Southwest Oncology Group clinical database to perform clinicopathologic correlations with the results of those studies.
OUTLINE: Serum is collected and stored for future correlative studies.
|Study Type :||Observational|
|Actual Enrollment :||939 participants|
|Official Title:||Central Lymphoma Serum Repository Protocol|
|Study Start Date :||March 2005|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||July 2011|
- Establishment of a Centralized Lymphoma Serum Repository for the Southwest Oncology Group [ Time Frame: July 2011 ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01000558
|Study Chair:||Richard I. Fisher, MD||James P. Wilmot Cancer Center|